Selecting suitable sites with access to patients meeting protocol eligibility requirements is paramount to study enrollment success in clinical research. To bolster site selection, ProSciento has a strong global network of clinical trial sites and specialized vendors, curated over nearly two decades of expertise in metabolic clinical research. Additionally, ProSciento’s PRO PASS® platform and database provide detailed diagnostic data to aid in optimizing I/E criteria and site selection based on patients that meet protocol eligibility. Overall, ProSciento’s depth and breadth of services help ensure streamlined site and vendor selection, improved enrollment, and accelerated study launch providing a dramatic and positive impact on the conduct of the entire study.
